Summary & Overview
HCPCS G2132: Frailty with Dispensed Dementia Medication
HCPCS Level II code G2132 designates patients aged 66–80 who had a documented frailty encounter during the measurement period and who received a dispensed medication for dementia during that period or in the prior year. The code is used to identify a clinically vulnerable cohort at the intersection of frailty and treated dementia, informing quality measurement, population health management, and care coordination efforts. Nationally, tracking this population matters for resource planning, geriatric care pathways, and medication safety surveillance.
The analysis covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find: benchmark context for prevalence and coding capture of this cohort; implications for performance measurement and care management workflows; and clinical context describing why frailty combined with dementia pharmacotherapy is a relevant target for quality programs. The report summarizes expected sites of service and data sources typically used to identify these patients, and flags where input data were not provided. Data not available in the input are noted where applicable.
Billing Code Overview
HCPCS Level II code G2132 identifies patients aged 66–80 years who have at least one claim or encounter for frailty during the measurement period and who had a dispensed medication for dementia either during the measurement period or in the year prior. This measure captures a specific clinical cohort defined by age, a frailty encounter, and evidence of dementia pharmacotherapy.
-
Service type: Medication-related quality measure / clinical population identification
-
Typical site of service: Ambulatory care settings, primary care clinics, specialty memory or geriatric clinics, and outpatient pharmacy dispensing records
Data not available in the input for modifiers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A typical patient is an 72-year-old Medicare beneficiary with clinically documented frailty (unintentional weight loss, exhaustion, low activity) seen in a primary care or geriatrics clinic during the measurement period. The patient has a prior diagnosis of Alzheimer disease and was dispensed a cholinesterase inhibitor during the year prior to the measurement period and again during the measurement period. The clinical workflow begins with a visit documenting frailty using clinical assessment and problem list entry, capture of medication dispensing history (e.g., donepezil, rivastigmine, galantamine, memantine) from the pharmacy or EHR, and coding of the encounter to support quality measurement. Typical sites of service include outpatient primary care clinics, geriatric clinics, home health visits for homebound patients, and long-term care or assisted living facility-based outpatient encounters. The service documents both the frailty encounter and evidence of a dispensed dementia medication within the specified time window for quality reporting using code G2132 on claims.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when documentation supports substantially greater work than usual for the encounter (rare for evaluation visits documenting frailty if more complex than typical). |